blinatumomab, ponatinib, Philadelphia Chromosome, bcr-abl1, ALL
Philadelphia-negative ALL, inotuzumab, blinatumomab, chemo-immunotherapy, salvage, outcome
BCL11B-rearrangement, BCL11B expression, T-ALL, MPAL T/M phenotype, optical genome mapping, partner genes
Area deprivation index, racial/ethnic disparity, clinical trials, stem cell transplant